Breaking News, Collaborations & Alliances

Matica Biotechnology, Texas A&M’s NCTM Partner to Support CGT Developers

Aim to create a seamless, powerful ecosystem that reduces costly barriers for CGT innovators.

Author Image

By: Charlie Sternberg

Associate Editor

Matica Biotechnology, a specialized contract development and manufacturing organization (CDMO) for cell and gene therapies (CGT), has entered into a strategic partnership with the National Center for Therapeutics Manufacturing (NCTM), part of the Texas A&M Engineering Experiment Station, to provide a comprehensive, end-to-end service platform that supports CGT developers from early research through IND submission, clinical development, and commercialization. By combining NCTM’s earl...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters